SHLT Valuation

SHL Telemedicine Ltd

Add to Watchlist

Advanced Chart

2.050

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

SHLT Relative Valuation

SHLT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SHLT is overvalued; if below, it's undervalued.

Historical Valuation

SHL Telemedicine Ltd (SHLT) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.58 is considered Undervalued compared with the five-year average of -1.67. The fair price of SHL Telemedicine Ltd (SHLT) is between 3.50 to 4.25 according to relative valuation methord. Compared to the current price of 2.05 USD , SHL Telemedicine Ltd is Undervalued By 41.48%.

Relative Value

Fair Zone

3.50-4.25

Current Price：2.05

41.48%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

0.60

P/B

Median3y

2.17

Median5y

2.94

-0.32

FCF Yield

Median3y

-1.39

Median5y

0.12

Competitors Valuation Multiple

The average P/S ratio for SHLT's competitors is 2.28, providing a benchmark for relative valuation. SHL Telemedicine Ltd Corp (SHLT) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap